Trials / Completed
CompletedNCT03742050
A Placebo-controlled Trial of Percutaneous Coronary Intervention for the Relief of Stable Angina
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 439 (actual)
- Sponsor
- Imperial College London · Academic / Other
- Sex
- All
- Age
- 18 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
ORBITA-2 is a double blinded randomised placebo-controlled trial comparing the effects of coronary angioplasty versus placebo procedure on symptoms of stable angina without background anti-anginal therapy. Follow-up will be at 12 weeks.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Percutaneous coronary intervention | Percutaneous coronary intervention with drug-eluting stents aiming to achieve complete revascularisation |
Timeline
- Start date
- 2018-11-12
- Primary completion
- 2023-09-06
- Completion
- 2023-09-06
- First posted
- 2018-11-15
- Last updated
- 2023-09-29
Locations
8 sites across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT03742050. Inclusion in this directory is not an endorsement.